Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene

被引:50
作者
Pieper, RO
Patel, S
Ting, SA
Futscher, BW
Costello, JF
机构
[1] LOYOLA UNIV, DEPT PHARMACOL, DIV HEMATOL ONCOL, MAYWOOD, IL 60153 USA
[2] LOYOLA UNIV, PROGRAM MOLEC BIOL, MAYWOOD, IL 60153 USA
[3] UNIV ARIZONA, ARIZONA CANC CTR, TUCSON, AZ 85724 USA
[4] LUDWIG INST CANC RES, SAN DIEGO, CA 92093 USA
关键词
D O I
10.1074/jbc.271.23.13916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant transcriptional inactivation of the non-X-linked human O-6-methylguanine DNA methyltransferase (MGMT) gene has been associated with loss of open chromatin structure and increases in cytosine methylation in the Sp1-binding region of the 5'-CpG island of the gene, To examine the necessity of these events for gene silencing, we]save isolated and characterized a subline of human MGMT+ T98G glioma cells, The subline, T98Gs, does not express MGMT activity or MGMT mRNA, and exhibits no in vivo DNA-protein interactions at Sp1-like binding sites in the MGMT 5'-CpG island. While the MGMT CPG island is less accessible to exogenously added restriction enzymes in T98Gs nuclei than in T98G nuclei, it is similarly methylated in both T98G and T98Gs cell lines 5' and 3' to the transcription factor binding sites, and similarly unmethylated in the region encompassing the binding sites, Inappropriate transcriptional inactivation of MGMT, therefore, does not require methylation of transcription factor binding sites within the 5'-CpG island. Rather, MGMT gene silencing and transcription factor exclusion from T98Gs MGMT CpG island binding sites is most closely associated with condensed chromatin structure, which is in turns indirectly influenced by distant sites of methylation.
引用
收藏
页码:13916 / 13924
页数:9
相关论文
共 42 条
[41]   CYTOSINE METHYLATION PREVENTS BINDING TO DNA OF A HELA-CELL TRANSCRIPTION FACTOR REQUIRED FOR OPTIMAL EXPRESSION OF THE ADENOVIRUS MAJOR LATE PROMOTER [J].
WATT, F ;
MOLLOY, PL .
GENES & DEVELOPMENT, 1988, 2 (09) :1136-1143
[42]  
WU RS, 1987, CANCER RES, V47, P6229